Vaping may trigger deadly lung disease like smoking: Study

Image
ANI Washington D.C. [USA]
Last Updated : Oct 23 2017 | 1:32 AM IST

Beware, vaping can be as bad as cigarettes, as it can cause the similar deadly lung diseases, warns a study.

According to researchers, e-cigarettes appear to trigger unique immune responses which cigarettes also trigger, according to a new research.

Senior study author Mehmet Kesimer from the University of North Carolina Chapel Hill and co-authors report findings from what they believe is the first study to use human airway samples to explore the harmful effects of e-cigarettes.

"There is confusion about whether e-cigarettes are 'safer' than cigarettes because the potential adverse effects of e-cigarettes are only beginning to be studied," Dr Kesimer stated.

A 2016 Surgeon General's report found that e-cigarette use increased by 900 percent among high school students from 2011 to 2015.

Also in 2016, the Food and Drug Administration extended its regulatory oversight of tobacco products to include e-cigarettes.

The study compared sputum samples from 15 e-cigarette users, 14 current cigarette smokers and 15 non-smokers.

They found e-cigarette users uniquely exhibited significant increases in:

Neutrophil granulocyte and neutrophil-extracellular-trap (NET) related proteins in their airways.

Although neutrophils are important in fighting pathogens, left unchecked neutrophils can contribute to inflammatory lung diseases, such as COPD and cystic fibrosis.

NETs are associated with cell death in the epithelial and endothelium, the tissues lining blood vessels and organs.

The authors wrote that more research is necessary to determine if this increase is associated with systemic inflammatory diseases, such as lupus, vasculitis, and psoriasis.

The study also found that e-cigarettes produced some of the same negative consequences as cigarettes.

Both e-cigarette and cigarette users exhibited significant increases in:

Biomarkers of oxidative stress and activation of innate defense mechanisms associated with lung disease. Among these biomarkers are aldehyde-detoxification and oxidative-stress-related proteins, thioredoxin (TXN), and matrix metalloproteinase-9 (MMP9).

The data showed that e-cigarettes have a signature of harm in the lung that is both similar and unique, which challenges the concept that switching from cigarettes to e-cigarettes is a healthier alternative.

The study appears in online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 23 2017 | 12:29 AM IST

Next Story